Minimal Residual Disease Testing Market Will Grow Fastest in Asia-Pacific

Posted by Aryan on July 13th, 2023

The minimal residual disease testing market will power at a rate of 15.1% by the end of this decade, to touch USD 3,570.1 million by 2030.

This development of the industry can be mostly credited to the increasing incidence of hematological menaces and solid tumors. 

Furthermore, the increasing healthcare spending, along with the increasing private and government investments in minimal residual disease research, will power the growth of the market in the years to come.

Next-generation sequencing and polymerase chain reaction are the commonly used methods for minimal residual disease testing, for the reason that they offer faster and more-precise results as opposed to others.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/minimal-residual-disease-testing-market/report-sample

APAC will grow the fastest in the years to come in the future. This growth can be credited to the growing incidence of lymphoma and leukemia, increasing spending of the government on the healthcare infra, obtainability of clinical labs, and easy access to novel diagnostic technologies. 

Moreover, survival rates have significantly increased in the past few years, mostly as a result of the progressions in the treatment, the effectiveness of which hinge on on stage of the cancer. ‘

The growing incidence of hematological malignancies and solid tumors, the requirement for minimal residual disease testing solution will continue to grow in the years to come.

About P&S Intelligence

P&S Intelligence is a market research and consulting firm shaping growth strategies for enterprises with a global as well as niche presence. We specialize in both syndicate and custom market research, creating insight-laden reports that allow customers to stay ahead at every curve. Our clients range from multi-billion-dollar behemoths across industries to up and coming MSMEs and startups. Moreover, with our new offering, government and public sector advisory services, we continue to trudge ahead in our quest for revolutionizing the way economies shape themselves in these ever-changing times.